🧬 RNAwiki
HomeFAT LOSSCagrilintide (± CagriSema)

Cagrilintide (± CagriSema)

Evidence: ★★★★☆ · Status: Not Approved

In plain English

A second gut-fullness hormone (amylin) stacked on top of GLP-1 — two different "I'm full" systems for bigger appetite suppression.

How it works

Long-acting amylin receptor (CALCR/RAMP) agonist; amylin slows gastric emptying and enhances satiety through a pathway complementary to GLP-1. CagriSema (cagrilintide + semaglutide) targets ~25% weight loss.

Molecular target & official sources

CALCR calcitonin/amylin receptor (NCBI Gene) · Examine: amylin

Bottom line

The likely next combo blockbuster; investigational.

Helps with: Lose Fat · Hormones & Testosterone · Gut Health

Stacks with

Shares a pathway — often paired with: Caffeine, Semaglutide (Ozempic / Wegovy / Rybelsus), Tirzepatide (Mounjaro / Zepbound), Retatrutide.

Availability & where to buy

Not widely approved. Not approved for general sale in most markets (Singapore included). Grey-market only — dose, purity and legality uncertain.

How it works: the GPCR → cAMP pathway →

Compare Cagrilintide (± CagriSema)

Common questions

Does Cagrilintide (± CagriSema) actually work?

Human-evidence rating: 4 of 5. The likely next combo blockbuster; investigational.

Is Cagrilintide (± CagriSema) legal or approved?

Regulatory status: Not Approved.